Novo Nordisk is working with GoodRx to offer a month’s supply of Ozempic for $499, or about half the list price, for self-paying patients. Ozempic, a drug approved for Type 2 diabetes, cardiovascular disease and kidney disease, has a list…
Pharmacy
The FDA has approved Novo Nordisk’s Wegovy to treat metabolic associated steatohepatitis, or MASH, in adults who have excessive scar tissue in the liver. MASH is a serious liver condition linked to obesity, Type 2 diabetes and high cholesterol, affecting…
Here are seven new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.
The FDA has issued warnings to manufacturers and distributors of unapproved animal-derived thyroid medications citing concerns over safety, effectiveness and quality. The drugs, often sold under names Armour Thyroid, NP thyroid and Natural Thyroid, are made from dried pig thyroid…
Health systems interested in building a central pharmacy should prioritize personalization and preparation, according to Melanie Massiah-White, vice president and chief pharmacy officer of Fairfax, Va.-based Inova Health System. “[Spend] time initially scoping services you hope to provide from your…
Advertisement
As semaglutide sees a surge in use, new research raises questions about the medication’s effects on muscle health. A study published Aug. 5 in Cell Metabolism and led by researchers at Salt Lake City-based University of Utah Health found that…
Texas is seeking more than $1 million from Eli Lilly in a lawsuit accusing the drugmaker of persuading physicians to prescribe its medications, including GLP-1s such as Mounjaro and Zepbound, through kickbacks. Texas Attorney General Ken Paxton filed the lawsuit…
The American Medical Association and 80 other physician associations are urging Congress to reject a bill that would allow pharmacists to evaluate, diagnose and treat patients in cases that currently require physician oversight. The Ensuring Community Access to Pharmacist Services…
Eastern Iowa Health Center recently opened a new pharmacy in Cedars Rapids to address a medication access gap after a Hy-Vee closed last summer, Corridor Business Journal reported Aug. 13. The pharmacy was under development for two years, but the…
The FDA has approved Insmed’s brensocatib, the first treatment for non-cystic fibrosis bronchiectasis, a chronic and progressive lung disease affecting about 500,000 people in the U.S. The drug was approved for use in adults and children 12 and older and…